Resveratrol plus carboxymethyl-β-glucan for children with respiratory diseases

Main Article Content

Cristiana Indolfi https://orcid.org/0000-0002-9513-193X
Giulio Dinardo https://orcid.org/0000-0002-9952-1206
Angela Klain https://orcid.org/0000-0001-7823-2125
Carolina Grella
Maria Maddalena Marrapodi
Fabio Decimo
Giorgio Ciprandi https://orcid.org/0000-0001-7016-8421
Michele Miraglia del Giudice https://orcid.org/0000-0002-8369-5957

Keywords

beta-glucans, children, nutraceutical, respiratory tract infections, resveratrol

Abstract

Respiratory infections in children, ranging from mild to severe, are a leading cause of school absences and medical visits, creating significant socio-economic burdens for families. Recent interest has focused on resveratrol, a natural polyphenol known for its antioxidant, anti-inflammatory, and antiviral properties. When combined with carboxymethyl-β-glucan (CM-glucan), a modified polysaccharide with immunostimulatory effects, this formulation has shown potential benefits in managing respiratory diseases.


Our research examines five randomized clinical trials investigating the efficacy of resveratrol and CM-glucan nasal solutions in children. The trials included children with recurrent respiratory infections (RRIs) and allergic rhinitis. The results demonstrate significant reductions in key respiratory symptoms, including nasal congestion, sneezing, coughing, and fever. In addition to symptomatic relief, the treatment was associated with fewer medical visits, decreased medication use, and reduced school absences. Importantly, the combination also showed efficacy in decreasing wheezing episodes in non-atopic children with RRIs and improving symptoms of allergic rhinitis. While these findings are promising, the studies are limited by small sample sizes and short-term follow-up periods, raising questions about the long-term efficacy and safety of the treatment. Mild and transient nasal irritation was the only reported side effect. Based on these concepts, the combination of resveratrol and carboxymethyl-β-glucan could be considered a valuable add-on strategy, complementing standard pharmacological treatments for pediatric respiratory infections and allergic conditions.

Abstract 162 | PDF Downloads 297 HTML Downloads 0 XML Downloads 7

References

1 Chiappini E, Santamaria F, Marseglia GL, Marchisio P, Galli L, Cutrera R, et al. Prevention of recurrent respiratory infections: Inter-society consensus. Ital J Pediatr. 2021;47(1):211. 10.1186/s13052-021-01150-0

2 Drago L, Ciprandi G, Brindisi G, Brunese FP, Dinardo G, Gori A, et al. Certainty and uncertainty in the biological activities of resveratrol. Food Front. 2024;5(3):849–54. 10.1002/fft2.3753

3 Francioso A, Mastromarino P, Masci A, d’Erme M, Mosca L. Chemistry, stability and bioavailability of resveratrol. Med Chem. 2014;10(3):237–45. 10.2174/15734064113096660053

4 Chen X, Song X, Zhao X, Zhang Y, Wang Y, Jia R, et al. Insights into the anti-inflammatory and antiviral mechanisms of resveratrol. Mediators Inflamm. 2022;2022:7138756. 10.1155/2022/7138756

5 Vestergaard M, Ingmer H. Antibacterial and antifungal properties of resveratrol. Int J Antimicrob Agents. 2019;53(6):716–23. 10.1016/j.ijantimicag.2019.02.015

6 Vetvicka V, Volny T, Saraswat-Ohri S, Vashishta A, Vancikova Z, Vetvickova J. Glucan and resveratrol complex—Possible synergistic effects on immune system. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007;151(1): 41–6. 10.5507/bp.2007.007

7 Costagliola G, Nuzzi G, Spada E, Comberiati P, Verduci E, Peroni DG. Nutraceuticals in viral infections: An overview of the immunomodulating properties. Nutrients. 2021;13(7):2410. 10.3390/nu13072410

8 Francioso A, Mastromarino P, Restignoli R, Boffi A, D’Erme M, Mosca L. Improved stability of trans-resveratrol in aqueous solutions by carboxymethylated (1,3/1,6)-β-D-glucan. J Agric Food Chem. 2014 Feb 19;62(7):1520–5. 10.1021/jf404155e

9 Schwager J, Richard N, Widmer F, Raederstorff D. Resveratrol distinctively modulates the inflammatory profiles of immune and endothelial cells. BMC Complement Altern Med. 2017;17(1):309. 10.1186/s12906-017-1823-z

10 Varricchio AM, Capasso M, Della Volpe A, Malafronte L, Mansi N, Varricchio A, et al. Resveratrol plus carboxymethyl-β-glucan in children with recurrent respiratory infections: A preliminary and real-life experience. Ital J Pediatr. 2014 Nov 23;40:93. 10.1186/s13052-014-0093-3

11 Baldassarre ME, Di Mauro A, Labellarte G, Pignatelli M, Fanelli M, Schiavi E, et al. Resveratrol plus carboxymethyl-β-glucan in infants with common cold: A randomized double-blind trial. Heliyon. 2020;6(4):e03814. 10.1016/j.heliyon.2020.e03814

12 Indolfi C, Mignini C, Valitutti F, Bizzarri I, Dinardo G, Klain A, et al. Effects of nasal solution incorporating resveratrol and carboxymethyl-β-glucan in preschool non-atopic children with wheezing. Nutrients. 2024;16(14):2197. 10.3390/nu16142197

13 Miraglia Del Giudice M, Maiello N, Capristo C, Alterio E, Capasso M, Perrone L, et al. Resveratrol plus carboxymethyl-β-glucan reduces nasal symptoms in children with pollen-induced allergic rhinitis. Curr Med Res Opin. 2014;30(10):1931–5. 10.1185/03007995.2014.938731

14 Miraglia Del Giudice M, Maiello N, Decimo F, Capasso M, Campana G, Leonardi S, et al. Resveratrol plus carboxymethyl-β-glucan may affect respiratory infections in children with allergic rhinitis. Pediatr Allergy Immunol. 2014;25(7):724–8. 10.1111/pai.12279

15 Rossi GA, Sacco O, Capizzi A, Mastromarino P. Can resveratrol-inhaled formulations be considered potential adjunct treatments for COVID-19? Front Immunol. 2021;12:670955. 10.3389/fimmu.2021.670955